Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.

MLA

Parrish, Nicholas F., et al. “Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin Α4β7.” PLoS Pathogens, vol. 8, no. 5, 2012, p. e1002686. EBSCOhost, https://doi.org/10.1371/journal.ppat.1002686.

APA

Parrish, N. F., Wilen, C. B., Banks, L. B., Iyer, S. S., Pfaff, J. M., Salazar-Gonzalez, J. F., Salazar, M. G., Decker, J. M., Parrish, E. H., Berg, A., Hopper, J., Hora, B., Kumar, A., Mahlokozera, T., Yuan, S., Coleman, C., Vermeulen, M., Ding, H., Ochsenbauer, C., … Doms, R. W. (2012). Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7. PLoS Pathogens, 8(5), e1002686. https://doi.org/10.1371/journal.ppat.1002686

Chicago

Parrish, Nicholas F, Craig B Wilen, Lauren B Banks, Shilpa S Iyer, Jennifer M Pfaff, Jesus F Salazar-Gonzalez, Maria G Salazar, et al. 2012. “Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin Α4β7.” PLoS Pathogens 8 (5): e1002686. doi:10.1371/journal.ppat.1002686.